Irinotecan Hydrochloride Trihydrate
CAS:136572-09-3
| Basic Information | |
| Product Name | Irinotecan Hydrochloride Trihydrate |
| Other Name | Irinotecan |
| Specification | 99% |
| Appearance | Pale yellow crystalline powder |
| CAS NO. | 136572-09-3 |
| Molecular Formula | C33H45ClN4O9 |
| Molecular Weight | 677.18 |
| Standard | USP 34 |
| Structure | |
| Function | |
| Irinotecan Hydrochloride Trihydrate is used for the treatment of digestive tumors such as stomach cancer, colon cancer, colorectal cancer, lung cancer; and also for the treatment of leukemia, mole and choriocarcinoma.
| |
| Application | |
|
Irinotecan Hydrochloride Trihydrate is used for the preparation of injection Pharmaceutical raw materials
| |
| Packing | |
| 100g/bag or as your requirement | |
| Storage | |
| Preserve in tight, light resistant containers at 2℃ - 8℃. | |
| Shelf life | |
| 24 months when properly stored. | |
CERTIFICATE OF ANALYSIS
| Appearance | Pale yellow crystalline powder |
| Identification | IR HPLC Chlorides |
| Microbial enumeration tests | ≤100cfu/g |
| Water determination | 7.0%~9.0% |
| Residue on ignition | ≤0.1% |
| Heavy metals | ≤10ppm |
| Residual solvent | |
| Methanol | ≤3000 ppm |
| Dichloromethane | ≤600 ppm |
| Methylbenzene | ≤890 ppm |
| Ethanol | ≤5000 ppm |
| Pyridine | ≤200 ppm |
| Related substances | |
| Irinotecan related compound B | ≤0.15% |
| Irinotecan related compound C | ≤0.10% |
| Any unspecified impurity | ≤0.10% |
| Total impurities | ≤0.5% |
| Chiral impurity(R-enantiomer) | ≤0.15% |
| Assay(on anhydrous basis) | 98.0%~102.0% |